Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX ® (Varenicline) Tablets Due to N-Nitroso Varenicline Content
Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable intake limit. As alternative suppliers have been approved in the United States, Pfizer (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 17, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Pfizer Recalls Four More Lots of Smoking Cessation Drug Chantix Pfizer Recalls Four More Lots of Smoking Cessation Drug Chantix
Pfizer has voluntarily recalled four additional lots of varenicline (Chantix) because of the presence of a nitrosamine impurity, marking a recall total now of 16 lots.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 17, 2021 Category: Cancer & Oncology Tags: Psychiatry News Alert Source Type: news
Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX ® (varenicline) Tablets Due to N- Nitroso Varenicline Content
Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily Intake (ADI) level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Pfizer Expands Recall of Smoking Cessation Drug Chantix Pfizer Expands Recall of Smoking Cessation Drug Chantix
The FDA says the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity potentially contained in the recalled varenicline lots.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 22, 2021 Category: Cancer & Oncology Tags: Psychiatry News Source Type: news
Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of CHANTIX ® (Varenicline) Tablets Due to N-Nitroso Varenicline Content
Pfizer is voluntarily recalling two lots of Chantix 0.5mg Tablets, two lots of Chantix 1 mg Tablets, and eight lots of a Chantix kit of 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily I (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 19, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Allows Impure Smoking Cessation Drug to Stay on the Market FDA Allows Impure Smoking Cessation Drug to Stay on the Market
To ensure uninterrupted access to varenicline, the FDA will allow distribution of the smoking cessation drug to continue; some lots of pills were found to contain the carcinogen N-nitrosodimethylamine.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2021 Category: Consumer Health News Tags: Psychiatry News Source Type: news
FDA Updates and Press Announcements on Nitrosamine in Varenicline (Chantix)
FDA Updates and Press Announcements on Nitrosamine in in Varenicline (Chantix) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Cytisine Not Noninferior to Varenicline for Smoking Cessation
Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 8, 2021 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Pharmacy, Psychiatry, Journal, Source Type: news
Cytisine Not Noninferior to Varenicline for Smoking Cessation
THURSDAY, July 8, 2021 -- Cytisine treatment fails to demonstrate noninferiority to varenicline treatment for smoking cessation, according to a study published in the July 6 issue of the Journal of the American Medical Association.
Ryan J.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2021 Category: Pharmaceuticals Source Type: news
Pfizer Pauses Distribution of Stop-Smoking Pill Chantix Pfizer Pauses Distribution of Stop-Smoking Pill Chantix
Pfizer told Reuters the distribution pause was ordered out of an abundance of caution while further testing is conducted. FDA approved varenicline, marketed as Chantix, in 2006.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 25, 2021 Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Alert Source Type: news
Medication may help heavy-drinking smokers improve their health
This study confirms that medications can play a role, Ray said, but she noted that it can be challenging for patients to take more than one prescribed medication.“Varenicline alone is doing a great job, and this trial indicates that there is not much room for naltrexone to make a difference,” Ray said. “But even medications like varenicline have their limitations. Medication is only part of the solution. There remains much research to be done on addict ions and how to treat them.”Ray says that those who wish to quit smoking and reduce drinking may consider talking to their doctor about the possibility of using vare...
Source: UCLA Newsroom: Health Sciences - June 15, 2021 Category: Universities & Medical Training Source Type: news
Varenicline Nasal Spray Efficacious for Dry Eye Varenicline Nasal Spray Efficacious for Dry Eye
Nasal spray reduces signs and symptoms of dry eye disease in phase 3 trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 7, 2021 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
Sharing Mayo Clinic: Daughter quits smoking to donate liver to her mom
When she learned that a liver transplant could save her mom's life, April Wilson didn't hesitate to stop smoking and say yes to being a living donor. April Wilson smoked for 25 years and tried many times to quit, but nothing seemed to work. "I tried everything," April says. "I used every replacement therapy, Chantix, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 4, 2021 Category: Databases & Libraries Source Type: news
Starting smoking cessation in hospitalized patients would reduce many premature deaths
(Florida Atlantic University) Each year in the U.S., about 30 million hospitalizations occur in individuals 18 and older. Of these, more than 7 million are current cigarette smokers whose average hospital stay is several days. Researchers say that starting smoking cessation therapy during hospitalization and maintaining high adherence post-discharge can markedly improve permanent quit rates in these patients with minimal to no side effects. Cessation therapy also should include long-term counseling and at least 90 days of a prescription drug, specifically, varenicline. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 25, 2021 Category: Cancer & Oncology Source Type: news
Oyster Point Pharma Announces FDA Acceptance for Filing New Drug Application for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease
PRINCETON, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 2, 2021 Category: Drugs & Pharmacology Source Type: news
